Dr. Reddy's Laboratories, Inc. is recalling 2,770 bags of Levetiracetam (generic Keppra) in 0.54% Sodium Chloride Injection because the internal infusion bags are incorrectly labeled. While the outer foil pouch correctly identifies the medication as 1,500 mg per 100 mL, the bag itself incorrectly states it is 1,000 mg per 100 mL. This discrepancy could lead to healthcare providers accidentally administering a 50% higher dose than intended, which may cause serious side effects. This drug is used for intravenous infusion and was distributed nationwide.
A dosing error where a patient receives 1,500 mg instead of the labeled 1,000 mg can result in an overdose, potentially leading to extreme drowsiness, agitation, or respiratory issues. Additionally, the label incorrectly lists the sodium chloride concentration, which could complicate treatment for patients with specific electrolyte restrictions.
Return the product for a refund and contact healthcare professionals for guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.